M&A: U.S. Deal Volume Hits $640.5 Billion
U.S. targeted mergers and acquisitions is the second-highest volume on record in the year to date, according to Dealogic.
There has been $640.5 billion worth of announced U.S. M&A through 3,790 deals so far in 2015. That level of activity is only behind 2007 when there was $705.3 billion worth of announced U.S. M&A through 4,056 deals during the same period.
There have been 14 announced U.S. merger and acquisitions so far in 2015 worth more than $10 billion. In total these 14 transactions are valued at $292.1 billion. That is the highest year to date volume of $10 billion plus announced deals on record, says Dealogic.
Healthcare M&A leads in $10 billion plus U.S. transactions with six deals. Teva Pharmaceutical’s $51.5 billion proposed hostile takeover of Mylan is the tenth-largest healthcare deal ever announced.
JPMorgan leads among the investment banks in U.S. merger and acquisitions advice. It has advised on $227 billion worth of announced U.S. takeovers. Goldman Sachs has advised on $195.6 billion and Morgan Stanley $185 billion.
The following is a table of $10 billion plus U.S. targeted and announced M&A transactions between January 1 and May 19 in the years between 2008 and 2015, according to Dealogic.